TRANSCRANIAL MAGNETIC STIMULATOR MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Transcranial Magnetic Stimulator Market, By Type (Deep Transcranial Magnetic Stimulator, Repetitive Transcranial Magnetic Stimulator, and Others), By Application (Depression Treatment, Tinnitus Treatment, Alzheimer’s Disease Treatment, Epilepsy Treatment, Stroke Rehabilitation, Parkinson’s Disease Treatment, and Others), By Frequency (Low-frequency RTMS and High-frequency RTMS), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)

Published In : Dec 2023
Code : CMI6466
Pages :212
Formats :
Excel and PDF
Industry : Medical Devices

Transcranial Magnetic Stimulator Market Size and Trends

The Transcranial Magnetic Stimulator (TMS) market size is expected to reach US$ 1,447.1 Mn by 2030, from US$ 638.4 Mn in 2023, at a CAGR of 12.4% during the forecast period.

Transcranial Magnetic Stimulator Market Trends

Integration with technological advancements: The integration of TMS systems with novel technologies such as electroencephalography (EEG), functional near-infrared spectroscopy (fNIRS), and functional magnetic resonance imaging (fMRI) is an emerging trend. The combination of TMS with imaging and recording techniques enables real-time monitoring and mapping of cortical responses. Companies are increasingly developing multi-modal TMS systems with such capabilities for research and enhanced therapy outcomes. Further, TMS is being combined with EEG, fNIRS, and EMG to derive neurophysiological biomarkers.
Development of innovative stimulation protocols and coils: Key players are investing in designing proprietary stimulation protocols and novel coil designs for deeper penetration, focused stimulation, and improved treatment efficiency. For instance, Stanford University has developed the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) TMS protocol that significantly reduces treatment duration. Brainsway’s H-Coil helps stimulate deeper brain structures. Magventure’s Cool-B65 butterfly coil enables deeper reach. The next-generation TMS systems offer shorter, faster, and more individualized treatments.
Rise of robotics and navigational TMS systems: Advanced TMS systems are incorporating robotic arms, stereotactic navigation, and individualized head modeling for precisely targeted stimulation of the affected brain regions. Robotics offers the advantages of optimizing coil positioning and orientation, consistent stimulation, and reducing human errors. Companies like Axilum Robotics, Rogue Research, and Magstim have developed robotic TMS systems. Navigation technology is making TMS therapy more accurate.
Emergence of home-use TMS devices: Compact and easy-to-use TMS devices are being introduced for at-home patient use under medical guidance. In May 2022, Neuronetics, a medical device company, received the U.S. FDA’s Breakthrough Device designation for its home-use TMS system. Home-based therapy can help improve access, reduce cost, and improve outcomes. Other companies like MindPod are also developing home TMS solutions. The emergence of home-based TMS presents a new trend in the market.